Innovation & Technology
Building the conditions for pharmaceutical innovation to scale in Barbados.
How We’re Accomplishing This
BPI is building an integrated innovation ecosystem that brings together research, technology, industry, and regulation to accelerate pharmaceutical innovation in Barbados and the wider Caribbean. Rather than developing isolated projects, BPI is creating the infrastructure and partnerships needed to translate scientific discovery into commercial products and advanced manufacturing capabilities.
BioMed X Barbados, launched in January 2026 through the EU's PharmaNext programme, is already applying artificial intelligence and precision medicine to improve the early detection of diabetic kidney disease. Looking further ahead, BPI's sector strategy sets out planned investments in ICH Zone IVb-compliant stability testing, technology transfer and intellectual property support, and regional bioequivalence capacity.
Together, these initiatives are creating a platform for technology transfer, clinical research, AI-enabled manufacturing, and pharmaceutical innovation, thereby strengthening regional competitiveness and attracting new investment.
Build With Us
Careers
Every role at BPI contributes to building the pharmaceutical infrastructure that the Caribbean depends on. Join a team working at the intersection of government, investment, manufacturing, and regional health policy.
The gateway is open. Ready to build with us?
Deliberately. Piece by piece. With the people it is for. If you are a partner, investor, or government, we would like to build with you.
